Fertilitätserhalt – Möglichkeiten und Grenzen

Fertilitätsprotektive Maßnahmen stellen einen integralen Bestandteil onkologischer Behandlungen von präpubertären Mädchen und Jungen oder Patienten und Patientinnen im reproduktiven Alter dar. Die verschiedenen fertilitätsprotektiven Techniken müssen im Rahmen eines multimodalen Konzepts individuell mit den Betroffenen besprochen werden. Eine zügige und zeitparallele Zusammenarbeit mit einem spezialisierten Zentrum ist dabei unerlässlich.

Schlüsselwörter

Fertilitätserhalt - Fertilitätsprotektion - Kryokonservierung - Ovarialgewebe - Oozyten

• Literatur

• 1 AWMF. S2k-Leitlinie Fertilitätserhalt bei onkologischen Erkrankungen. AWMF Register-Nr.: 015/082. 2017 Accessed July 03, 2023 at: https://register.awmf.org/de/leitlinien/detail/015–082
• 2 Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Human Reprod 2003; 18: 117-121
• 3 Teh WT, Stern C, Chander S. et al. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int 2014; 2014: 482968
• 4 Rodriguez-Wallberg KA, Karlstrom PO, Rezapour M. et al. Full-term newborn after repeated ovarian tissue transplants in a patient treated for Ewing sarcoma by sterilizing pelvic irradiation and chemotherapy. Acta Obstet Gynecol Scand 2015; 94: 324-328
• 5 Lambertini M, Del Mastro L, Pescio MC. et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016; 14: 1
• 6 Partridge A, Pagani O, Niman S. et al. Abstract GS4–09: Pregnancy outcome and safety of interrupting therapy for women with endocrine responsive breast cancer: primary results from the POSITIVE trial (IBCSG 48–14/BIG 8–13). Cancer Res 2023; 83: GS4–09
• 7 Lambertini M, Moore HCF, Leonard RCF. et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol 2018; 36: 1981-1990
• 8 Del Mastro L, Ceppi M, Poggio F. et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev 2014; 40: 675-683
• 9 Chen H, Xiao L, Li J. et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2019; (03) CD008018
• 10 Moore HC, Unger JM, Phillips KA. et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015; 372: 923-932
• 11 Demeestere I, Brice P, Peccatori FA. et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol 2016; 34: 2568-2574
• 12 Hoekman EJ, Broeders E, Louwe LA. et al. Ovarian function after ovarian transposition and additional pelvic radiotherapy: a systematic review. Eur J Surg Oncol 2019; 45: 1328-1340
• 13 von Wolff M, Thaler CJ, Frambach T. et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009; 92: 1360-1365
• 14 Cobo A, García-Velasco JA, Remohí J. et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril 2021; 115: 1091-1101
• 15 Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod BioMed Online 2009; 18: 769-776
• 16 Dittrich R, Lotz L, Keck G. et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2012; 97: 387-390
• 17 Beckmann MW, Lotz L, Toth B. et al. Concept paper on the technique of cryopreservation, removal and transplantation of ovarian tissue for fertility preservation. Geburtshilfe Frauenheilkd 2019; 79: 53-62
• 18 Khattak H, Malhas R, Craciunas L. et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis. Hum Reprod Update 2022; 28: 400-416
• 19 Lotz L, Bender-Liebenthron J, Dittrich R. et al. Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT network. Human Reprod 2022; 37: 2787-2796
• 20 Demeestere I, Simon P, Dedeken L. et al. Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 2015; 30: 2107-2109
• 21 Poirot C, Abirached F, Prades M. et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012; 379: 588
• 22 Ernst E, Kjærsgaard M, Birkebæk NH. et al. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer 2013; 49: 911-914
• 23 Dolmans MM, von Wolff M, Poirot C. et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril 2021; 115: 1102-1115
• 24 Dittrich R, Lotz L, Mueller A. et al. Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol 2013; 11: 19
• 25 Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 2013; 100: 1180-1186
• 26 Jahnukainen K, Ehmcke J, Hou M. et al. Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab 2011; 25: 287-302
• 27 Kliesch S, Kamischke A, Cooper TG, Nieschlag E. Kryokonservierung menschlicher Spermien zur Zeugungsreserve. In: Nieschlag E, Behre HM, Nieschlag S. Andrologie: Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Berlin, Heidelberg: Springer; 2009: 515-531
• 28 Marconi M, Keudel A, Diemer T. et al. Combined trifocal and microsurgical testicular sperm extraction is the best technique for testicular sperm retrieval in low-chance nonobstructive azoospermia. Eur Urol 2012; 62: 713-719